original ) (raw )Targeting immune checkpoints in breast cancer: an update of early results
Cinzia Solinas
ESMO Open, 2017
View PDFchevron_right
Immunotherapy for the treatment of breast cancer: checkpoint blockade, cancer vaccines, and future directions in combination immunotherapy
David Page
Clinical advances in hematology & oncology : H&O, 2016
View PDFchevron_right
Targeted immunotherapy with a checkpoint inhibitor in combination with chemotherapy: A new clinical paradigm in the treatment of triple-negative breast cancer
Semir Vranić , BJBMS Journal
Targeted immunotherapy with a checkpoint inhibitor in combination with chemotherapy: A new clinical paradigm in the treatment of triple-negative breast cancer, 2019
View PDFchevron_right
An overview of immune checkpoint inhibitors in breast cancer
Nicla La Verde
Exploration of Targeted Anti-tumor Therapy
View PDFchevron_right
A Retrospective Look at Immunotherapy: Where We Are Now and The Future It Holds for Breast Cancer Patients
Abdul Rashid Abdulai
View PDFchevron_right
Current Landscape of Immunotherapy in Breast Cancer
Jane Perlmutter
JAMA Oncology, 2019
View PDFchevron_right
The role of immune checkpoint inhibitors in triplenegative breast cancer: recent developments and future perspectives
Journal of Cancer Metastasis and Treatment
Journal of Cancer Metastasis and Treatment, 2021
View PDFchevron_right
Immunotherapy in Breast Cancer: When, How, and What Challenges?
Beatriz Henriques
Biomedicines
View PDFchevron_right
The Immune Landscape of Breast Cancer: Strategies for Overcoming Immunotherapy Resistance
Małgorzata Bajor
Cancers
View PDFchevron_right
Where do the immune checkpoint inhibitors stand in the management of triple negative breast cancer?
Fadi Karak
Immunotherapy
View PDFchevron_right
Immune Checkpoint Blockade in HER2-Positive Breast Cancer: What Role in Early Disease Setting?
Cinzia Solinas
Cancers, 2021
View PDFchevron_right
Immunotherapy in HER2-positive breast cancer: state of the art and future perspectives
Eriseld Krasniqi
Journal of Hematology & Oncology, 2019
View PDFchevron_right
Immune checkpoints in aggressive breast cancer subtypes
Izabela Zawlik
Neoplasma, 2016
View PDFchevron_right
Immunotherapy for the treatment of breast cancer
Alejandro Nicola Candia
Expert Opinion on Biological Therapy, 2017
View PDFchevron_right
Checkpoint Inhibitors and Their Application in Breast Cancer
Davide Bedognetti
Breast Care, 2016
View PDFchevron_right
Immunotherapy: A Challenge of Breast Cancer Treatment
Marilina García Aranda
Cancers, 2019
View PDFchevron_right
Immune approaches to the treatment of breast cancer, around the corner?
Angela Esposito
Breast Cancer Research, 2014
View PDFchevron_right
Immunology and immunotherapy in breast cancer
Anna Artemyeva
Cancer Biology & Medicine
View PDFchevron_right
Differential expression of novel immune checkpoint receptors on tumor-infiltrating lymphocytes in patients with locally advanced breast cancer after neoadjuvant chemotherapy
Mustafa Tükenmez
Neoplasma, 2021
View PDFchevron_right
Immunological Landscape of HER-2 Positive Breast Cancer
Ana Lluch
Cancers
View PDFchevron_right
A narrative review of immune checkpoint inhibitors in early stage triple negative breast cancer
Terry En Gee
2021
View PDFchevron_right
Tumor-Infiltrating Lymphocytes and Breast Cancer: Are Immune Checkpoint Inhibitors Ready for Prime Time in Breast Cancer?
Miloš Kostić
Acta Facultatis Medicae Naissensis, 2016
View PDFchevron_right
Immune-Based Therapy in Triple-Negative Breast Cancer: From Molecular Biology to Clinical Practice
Francesca Carlino
Cancers
View PDFchevron_right
Immunotherapeutic Approaches in Triple-Negative Breast Cancer: State of the Art and Future Perspectives
Lamiae AMAADOUR
International Journal of Breast Cancer, 2020
View PDFchevron_right
Complimentary mechanisms of dual checkpoint blockade expand unique T-cell repertoires and activate adaptive anti-tumor immunity in triple-negative breast tumors
Alan Korman
Oncoimmunology, 2018
View PDFchevron_right
Biological and molecular studies on specific immune cells treated with checkpoint inhibitors for the thera-personal approach of breast cancer patients (ex-vivo study)
Dr.Enas Radwan
Oncology Research
View PDFchevron_right
Improving the Odds in Advanced Breast Cancer With Combination Immunotherapy: Stepwise Addition of Vaccine, Immune Checkpoint Inhibitor, Chemotherapy, and HDAC Inhibitor in Advanced Stage Breast Cancer
Sofia Gameiro
Frontiers in Oncology, 2021
View PDFchevron_right
Breast cancer resistance mechanisms: challenges to immunotherapy
ann hanna
Breast Cancer Research and Treatment, 2021
View PDFchevron_right
Breast Cancer Multi-Therapy and Immune System Activation, Checkpoint Modulators, Signal Inhibitors and T Cells Reprogramming
Raul Barrera
International Conference on Cancer Research 2019, 2019
View PDFchevron_right
Immune landscape of inflammatory breast cancer suggests vulnerability to immune checkpoint inhibitors
Emilie Mamessier
OncoImmunology
View PDFchevron_right
Analyzing the role of the immune system and Immunotherapy in Triple Negative Breast Cancer (TNBC) Management
The Journal of Middle East and North Africa Sciences
The Journal of Middle East and North Africa Sciences, 2022
View PDFchevron_right